Bisphenol A diglycidyl ether


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:12419697IVTH0.00000000000001 - 0.0001 M 0.00000000000001 - 0.0001 MCancer phenotypeEndocrine-mediated cancer
PMID:17426428IVR1500 mg/kg/day -No significant effects observed-
IVR3000 mg/kg/day -No significant effects observed-
IVR375 mg/kg/day 375 mg/kg/dayDecreased spleen weightsImmunological endocrine-mediated perturbations
IVR375 mg/kg/day 375 mg/kg/dayIncreased weights of epididymis in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR375 mg/kg/day 375 mg/kg/dayIncreased prostate weights in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR375 mg/kg/day 375 mg/kg/dayIncreased brain weights in offspringDevelopmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations
IVR375 mg/kg/day 375 mg/kg/dayIncreased testis weightsReproductive endocrine-mediated perturbations
IVR375 mg/kg/day 375 mg/kg/dayIncreased weights of adrenal gland in offspringDevelopmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.